Hyloris Pharmaceuticals SA (EBR:HYL)
Belgium
· Delayed Price · Currency is EUR 6.12
+0.22 (3.73%)
Mar 31, 2025, 3:54 PM CET
Hyloris Pharmaceuticals Market Cap
Hyloris Pharmaceuticals has a market cap or net worth of €171.36 million as of April 1, 2025. Its market cap has decreased by -44.86% in one year.
Market Cap
171.36M
Enterprise Value
149.03M
Revenue
10.04M
Ranking
n/a
PE Ratio
n/a
Stock Price
€6.12
Market Cap Chart
Since June 29, 2020, Hyloris Pharmaceuticals's market cap has decreased from 244.70M to 171.36M, a decrease of -29.97%. That is a compound annual growth rate of -7.22%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 31, 2025 | 171.36M | -6.42% |
| Dec 31, 2024 | 183.12M | -48.71% |
| Dec 29, 2023 | 357.00M | 14.84% |
| Dec 30, 2022 | 310.88M | -30.44% |
| Dec 31, 2021 | 446.90M | 82.11% |
| Dec 31, 2020 | 245.41M | 0.29% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| argenx SE | 33.67B |
| UCB SA | 31.23B |
| Financière de Tubize | 5.76B |
| Fagron NV | 1.40B |
| Ion Beam Applications | 326.83M |
| Nyxoah | 264.99M |
| Onward Medical | 207.52M |
| Sequana Medical NV | 51.68M |